Skip to main content
HR 654 117th Congress House Health Cardiovascular and respiratory health Drug, alcohol, tobacco use Emergency medical services and trauma care Health programs administration and funding Health promotion and preventive care Infectious and parasitic diseases

Drug-Free Communities Pandemic Relief Act

Introduced: February 1, 2021 Introduced by: Joyce, David P. Republican · Ohio See on congress.gov
 Everywhere this bill has been 19 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 21, 2021
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Oct 20, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 395 - 30 (Roll no. 321). (text: CR 10/19/2021 H5650)
Oct 20, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 395 - 30 (Roll no. 321).(text: CR 10/19/2021 H5650)
Oct 20, 2021
Considered as unfinished business. (consideration: CR H5700)
Oct 20, 2021
The title of the measure was amended. Agreed to without objection.
Oct 20, 2021
Motion to reconsider laid on the table Agreed to without objection.
Oct 19, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 19, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 654.
Oct 19, 2021
Considered under suspension of the rules. (consideration: CR H5650-5651)
Oct 19, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 19, 2021
Placed on the Union Calendar, Calendar No. 106.
Oct 19, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-146.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Feb 2, 2021
Referred to the Subcommittee on Health.
Feb 1, 2021
Referred to the House Committee on Energy and Commerce.
Feb 1, 2021
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Oct 20, 2021 House · vote #321 On Motion to Suspend the Rules and Pass, as Amended Passed 39530 See who voted →
 Plain-English summary Congressional Research Service

Drug-Free Communities Pandemic Relief Act

This bill authorizes the Drug-Free Communities Support Program, subject to certain limitations, to waive matching funds requirements applicable to certain grants for reducing substance use among youth. Before waiving these requirements, the program must determine that a grantee is unable to raise funds because of the COVID-19 emergency.

Currently, the Office of National Drug Control Policy administers this program, and community coalitions that receive the grants must match a specified percentage of the federal award amount with nonfederal funds, including in-kind contributions.

What's happening now October 21, 2021

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

 Committees of jurisdiction 3